Theravance Biopharma Long Term Deferred Assets (Quarterly) Trends

Theravance Biopharma, Inc. (TBPH)

20.42 +0.41 (+2.05%) USD | NASDAQ | Jan 20, 16:00

20.37 -0.05 (-0.24%) Pre-Market: 20:00

View Long Term Deferred Assets (Quarterly) for TBPH.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Corcept Therapeutics, Inc.	Upgrade
Perspective Therapeutics, Inc.	--
Skye Bioscience, Inc.	--
Kyntra Bio, Inc.	--
Myomo, Inc.	--